These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34481696)

  • 21. Measles outbreak in Juneau, Alaska, 1996: implications for future outbreak control strategies.
    Landen MG; Beller M; Funk E; Rolka HR; Middaugh J
    Pediatrics; 1998 Dec; 102(6):E71. PubMed ID: 9832599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of cool water pack preparation on vaccine vial temperatures in refrigerators.
    Goldwood G; Diesburg S
    Vaccine; 2018 Jan; 36(1):128-133. PubMed ID: 29174313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects for the eradication of infectious diseases.
    Stuart-Harris C
    Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of a measles outbreak response immunization campaign: Maroua, Cameroon, 2009.
    Goodson JL; Sosler S; Pasi O; Johnson T; Kobella M; Monono ME; Uzicanin A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S252-9. PubMed ID: 21666170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin.
    Zipursky S; Djingarey MH; Lodjo JC; Olodo L; Tiendrebeogo S; Ronveaux O
    Vaccine; 2014 Mar; 32(13):1431-5. PubMed ID: 24559895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A limited measles outbreak in a highly vaccinated US boarding school.
    Yeung LF; Lurie P; Dayan G; Eduardo E; Britz PH; Redd SB; Papania MJ; Seward JF
    Pediatrics; 2005 Dec; 116(6):1287-91. PubMed ID: 16322148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
    Oteri J; Idi Hussaini M; Bawa S; Ibizugbe S; Lambo K; Mogekwu F; Wiwa O; Seaman V; Kolbe-Booysen O; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C29-C37. PubMed ID: 33478790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using oral polio vaccine beyond the cold chain: a feasibility study conducted during the national immunization campaign in Mali.
    Halm A; Yalcouyé I; Kamissoko M; Keïta T; Modjirom N; Zipursky S; Kartoglu U; Ronveaux O
    Vaccine; 2010 Apr; 28(19):3467-72. PubMed ID: 20197147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria.
    Utazi CE; Aheto JMK; Wigley A; Tejedor-Garavito N; Bonnie A; Nnanatu CC; Wagai J; Williams C; Setayesh H; Tatem AJ; Cutts FT
    Vaccine; 2023 Jan; 41(1):170-181. PubMed ID: 36414476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of vaccination coverage, individual behaviors, and the public health response in the control of measles epidemics: an agent-based simulation for California.
    Liu F; Enanoria WT; Zipprich J; Blumberg S; Harriman K; Ackley SF; Wheaton WD; Allpress JL; Porco TC
    BMC Public Health; 2015 May; 15():447. PubMed ID: 25928152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rehabilitation of the expanded programme on immunization in Sudan following a poliomyelitis outbreak.
    ElZein HA; Birmingham ME; Karrar ZA; Elhassan AA; Omer A
    Bull World Health Organ; 1998; 76(4):335-41. PubMed ID: 9803584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of a locally produced hepatitis B vaccine with the birth dose stored outside the cold chain in rural Vietnam.
    Hipgrave DB; Tran TN; Huong VM; Dat DT; Nga NT; Long HT; Van NT; Maynard JE; Biggs BA
    Am J Trop Med Hyg; 2006 Feb; 74(2):255-60. PubMed ID: 16474080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles vaccination coverage in high-incidence areas of the Western Cape, following the mass vaccination campaign.
    Bernhardt GL; Cameron NA; Willems B; Boulle A; Coetzee D
    S Afr Med J; 2013 Jan; 103(3):181-6. PubMed ID: 23472696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles outbreaks: what does it represent for the elimination strategy in the region of the Americas? A call for the action.
    Avila-Aguero ML; Camacho-Badilla K; Ulloa-Gutierrez R
    Expert Rev Vaccines; 2015; 14(8):1043-5. PubMed ID: 26065443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outbreak of measles in a highly vaccinated secondary school population.
    Sutcliffe PA; Rea E
    CMAJ; 1996 Nov; 155(10):1407-13. PubMed ID: 8943928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population.
    van Boven M; Kretzschmar M; Wallinga J; O'Neill PD; Wichmann O; Hahné S
    J R Soc Interface; 2010 Nov; 7(52):1537-44. PubMed ID: 20392713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the cold chain and follow-up of the potency of the antimeasles vaccine in the field].
    Camacho-Amor ML; Valdespino-Gómez JL; Ayala-González M; Díaz-Ortega JL; González-Velázquez MS; Morales-Romo A; Chávez-San Juan R
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):506-11. PubMed ID: 2206417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.